3rd Quarter - Report

NVG, LLC for ALEXION PHARMACEUTICALS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

The Budget Control Act of 2011 (P.L. 112-25): Data exclusivity

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
ANDREA LARUE New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Implementation of The Patient Protection Affordable Care Act (P.L. 111-148); Biosimilar provisions.

LobbyistCovered position, as disclosed
LISA GERMAN FOSTER —
ANDREA LARUE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.